A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.

Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.

A triple therapy approach of warfarin, clopidogrel and aspirin substantially reduces the risk of ischemic stroke and stent thrombosis compared to dual antiplatelet therapy (DAPT), according to a meta-analysis of patients with atrial fibrillation (AFib) undergoing coronary stenting. However, the three-medication strategy is associated with a higher bleeding risk.

Coronary artery bypass graft (CABG) surgery guided by fractional flow reserve (FFR) significantly reduced the incidence of death or myocardial infarction when compared to angiography-guided CABG, according to an observational study with an average follow-up of seven years.

Nitric oxide administration during and after multiple-valve heart surgery significantly reduced patients’ chances of developing acute and chronic kidney problems, according to a randomized trial published in the American Journal of Respiratory and Critical Care Medicine.

Just a week after Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program, CMS sent a letter to the hospital saying it will cut off funding for the program beginning Aug. 17.

Sunil V. Rao, MD, will become the editor-in-chief of the American Heart Association’s journal Circulation: Cardiovascular Interventions on July 1.

The FDA announced on June 21 it has approved the Eversense Continuous Glucose Monitoring (CGM) system, the first fully implantable product of its kind. The device can be worn for up to 90 days, whereas most CGMs are replaced every week or two.